Medical companies are subscribing to the StrainSecure platform, which provides consumers with tracking, testing and authentication for strains of medical cannabis. The platform is the first of its kind to track cannabis IP (Intellectual Property), Robert Galarza, the company CEO, has stated that the blockchain technology reduces the costs for testing quality-control on cannabis and streamlines the admin process. Galarza declared that problems previously seen in the industry with corrupt supply chains have been overcome, resulting with the platform providing customers with live data on each product purchased. The company has expressed their belief in the power of blockchain technology for data management, and aim to supply a useful tool for the growing demand of medical cannabis.
Latest News